2025-05-15FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canalDrugs Zynyz (retifanlimab-dlwr) · Anti-PD-1 antibody, carboplatin · Platinum agent, paclitaxel · TaxaneConditionGastrointestinal
2024-02-13FDA approves irinotecan liposome for first-line treatment of metastatic pancreatic adenocarcinomaTrial NAPOLI 3Drugs Onivyde (irinotecan liposome) · Topoisomerase I inhibitor, oxaliplatin · Platinum agentConditionGastrointestinal
2022-09-02FDA approves durvalumab for locally advanced or metastatic biliary tract cancerTrial TOPAZ-1Drugs Imfinzi (durvalumab) · Anti-PD-L1 antibody, gemcitabine · Pyrimidine analog, cisplatin · Platinum agentConditionGastrointestinal